11/19
04:32 pm
rvnc
Form 4 Revance Therapeutics, For: Nov 18 Filed by: Hollander David
Low
Report
Form 4 Revance Therapeutics, For: Nov 18 Filed by: Hollander David
11/19
04:01 pm
rvnc
Form 8-K Revance Therapeutics, For: Nov 19
Low
Report
Form 8-K Revance Therapeutics, For: Nov 19
11/12
09:32 am
rvnc
Form 8-K Revance Therapeutics, For: Nov 12
Medium
Report
Form 8-K Revance Therapeutics, For: Nov 12
11/7
04:23 pm
rvnc
Form 10-Q Revance Therapeutics, For: Sep 30
High
Report
Form 10-Q Revance Therapeutics, For: Sep 30
11/7
04:14 pm
rvnc
Form 8-K Revance Therapeutics, For: Nov 07
High
Report
Form 8-K Revance Therapeutics, For: Nov 07
11/1
09:25 am
rvnc
Form 8-K Revance Therapeutics, For: Nov 01
Low
Report
Form 8-K Revance Therapeutics, For: Nov 01
10/31
01:20 pm
rvnc
Form SCHEDULE 13G/A Revance Therapeutics, Filed by: FRANKLIN RESOURCES INC
Low
Report
Form SCHEDULE 13G/A Revance Therapeutics, Filed by: FRANKLIN RESOURCES INC
10/28
06:02 am
rvnc
Form 8-K Revance Therapeutics, For: Oct 24
High
Report
Form 8-K Revance Therapeutics, For: Oct 24
10/23
07:17 pm
rvnc
Form SC 13G/A Revance Therapeutics, Filed by: GIC Private Ltd
Low
Report
Form SC 13G/A Revance Therapeutics, Filed by: GIC Private Ltd
10/18
09:29 am
rvnc
Form 8-K Revance Therapeutics, For: Oct 18
Low
Report
Form 8-K Revance Therapeutics, For: Oct 18
10/7
10:08 am
rvnc
Form SC 13G/A Revance Therapeutics, Filed by: Capital World Investors
Low
Report
Form SC 13G/A Revance Therapeutics, Filed by: Capital World Investors
10/4
07:33 am
rvnc
Form 8-K Revance Therapeutics, For: Oct 03
Low
Report
Form 8-K Revance Therapeutics, For: Oct 03
9/23
07:16 am
rvnc
Form 8-K Revance Therapeutics, For: Sep 19
High
Report
Form 8-K Revance Therapeutics, For: Sep 19
9/16
05:01 pm
rvnc
Form SC 13G Revance Therapeutics, Filed by: Beryl Capital Management LLC
Low
Report
Form SC 13G Revance Therapeutics, Filed by: Beryl Capital Management LLC
9/9
04:07 pm
rvnc
Form 8-K Revance Therapeutics, For: Sep 09
Low
Report
Form 8-K Revance Therapeutics, For: Sep 09
9/9
10:41 am
rvnc
Form SC 13G/A Revance Therapeutics, Filed by: Capital World Investors
Neutral
Report
Form SC 13G/A Revance Therapeutics, Filed by: Capital World Investors
9/5
05:28 pm
rvnc
Form SC14D9C Revance Therapeutics, Filed by: Revance Therapeutics, Inc.
Low
Report
Form SC14D9C Revance Therapeutics, Filed by: Revance Therapeutics, Inc.
9/5
04:53 pm
rvnc
Form SC TO-C Revance Therapeutics, Filed by: Crown Laboratories, Inc.
Low
Report
Form SC TO-C Revance Therapeutics, Filed by: Crown Laboratories, Inc.
8/28
06:01 am
rvnc
Form 8-K Revance Therapeutics, For: Aug 27
Low
Report
Form 8-K Revance Therapeutics, For: Aug 27